News

Featured servicesGeneral newsMedia releasesResearch

World first: 3D bio-printer installed at Peter Mac to accelerate cancer research

December 19, 2018
Peter Mac today installed the first model of an Australian-designed 3D bio-printer, which promises to dramatically accelerate research into potential new cancer drugs.
Read more
General newsMedia releasesResearchClinical research & trials

CAR-T Therapy approved by TGA for two aggressive blood cancers

December 19, 2018
Peter MacCallum Cancer Centre welcomes the Therapeutic Goods Administration (TGA) announcement that Novartis Kymriah® (tisagenlecleucel, formerly CTL019) 
has been approved for treating two aggressive blood cancers.
Read more
Professor_John_seymour_speaking_at_ASH_2018
Research

Peter Mac researchers present 40 papers at the prestigious American Society of Hematology (ASH) conference

December 14, 2018
Professors John Seymour, Mark Dawson and Sarah-Jane Dawson, and Dr Piers Blombery, spoke as presenting authors at the ASH annual scientific meeting in San Diego recently. Attendees learned the latest about their discoveries and successful clinical trials at Peter Mac. These presentations were among a total of 40 papers delivered with Haematology staff as contributing authors, including 16 oral presentations.
Read more
General newsClinical research & trials

Peter Mac is delivering more world-class cancer research to Albury Wodonga and Bendigo

December 13, 2018
In a Victorian first, Peter Mac is expanding its services to patients at the Albury-Wodonga Regional Cancer Centre and Bendigo Health, with new initiatives combining world-class research and remote delivery of clinical trials.
Read more
General newsResearchClinical research & trials

NHMRC grants to fund broad pipeline of research at Peter Mac

December 13, 2018
Peter Mac research projects have received more than $17.6m in the latest grant round from the National Health and Medical Research Council (NHMRC).
Read more
Professor Bernhard Riedel
General newsResearch

Study to determine if anaesthetic used in cancer surgery impacts on patient outcomes

December 10, 2018
Surgery is a central tenet of cancer care, with around 60% of cancer patients requiring this as part of their treatment. Peter Mac's Professor Bernhard Riedel will lead an international study that will determine if the type of anaesthetic used in cancer surgery affects patient recovery and survival rates.
Read more
General newsResearch

Cancer mutation identified as driver of resistance to breakthrough drug

December 5, 2018
Melbourne researchers have identified a gene mutation in the leukaemia cells of patients who become resistant to venetoclax, a discovery which can be used to identify those at-risk of relapse and help improve outcomes from this breakthrough blood cancer drug.
Read more
General newsResearchClinical research & trials

Peter Mac researchers find new treatment for Mantle-Cell Lymphoma

December 4, 2018
Researchers at Peter Mac have discovered a genetic mutation which may lead to a new combination drug treatment to be tested in forthcoming clinical trials in Mantle Cell Lymphoma (MCL) patients.
Read more
General newsMedia releases

Minister announces cancer drug listings on the PBS

November 30, 2018
Peter Mac was delighted to host The Hon. Greg Hunt MP, Minister for Health, to announce important changes to the PBS which will provide or improve subsidised access to life-changing cancer drugs.
Read more
General news

Peter Mac says No to Family Violence

November 29, 2018
Peter Mac is getting behind the United Nations' 16 Days of Activism to End Gender Based Violence campaign that runs 25 November to 10 December.
Read more